openPR Logo
Press release

COVID-19 Pipline landscape Report 2022 - Clinical Trials, FDA Approvals and Therapies by DelveInsight

01-02-2023 06:56 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

COVID-19 Pipline

COVID-19 Pipline

COVID-19 pipeline constitutes 420+ key companies continuously working towards developing 520+ COVID-19 treatment therapies, analyzes DelveInsight

COVID-19 is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first isolated and identified in patients who were exposed at a seafood market in Wuhan City, Hubei Province, China in December 2019. Similar to findings related to SARS-CoV and Middle East respiratory syndrome coronavirus, SARS-CoV-2 is believed to cross species to initiate primary human infections; it is now spread primarily by human-to-human transmission.

DelveInsights, "COVID-19 - Competitive landscape, 2022," report provides comprehensive insights about 420+ companies and COVID-19 drugs in COVID-19 inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

To know more about the COVID-19 Competitive landscape report, click here: https://www.delveinsight.com/report-store/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the COVID-19 Competitive landscape report:

• Leading COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.

• Key COVID-19 therapies in various stages of development include SKYCovione, Sotrovimab, Sargramostim, Tradipitant, XAV-19, MAD0004J08, RESP301, Niclosamide, Sinapultide, MAS-825, Maraviroc, Abivertinib, Ebselen, Duvelisib, TCB008 and Others.

• In April 2022, Direct Biologics, announced that the US Food and Drug Administration has awarded their EV drug product ExoFlo with a regenerative Medicine Advanced Therapy designation for the treatment of Acute Respiratory Distress Syndrome associated with COVID-19.

DelveInsight's COVID-19 Report covers around 520+ products under different phases of clinical development like
• Assessment by COVID-19 Product Type
• Assessment by Stage and Product Type of COVID-19
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration of COVID-19
• Assessment by COVID-19 Molecule Type
• Assessment by Stage and Molecule Type of COVID-19

Emerging COVID-19 Drugs Under Different Phases of Clinical Development Include:

Some of the COVID-19 therapies are Sotrovimab, SKYCovione and Many Others.

Further COVID-19 product details are provided in the report. Download the COVID-19 Pipeline report to learn more about the emerging COVID-19 therapies at: https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key companies in the COVID-19 Therapeutics Market:

Some of the COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.

Request for Sample PDF Report to know in detail about the recent developments and

advancements in COVID-19 clinical trials- https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content (TOC)

1. COVID-19 Pipeline Report Introduction
2. COVID-19 Pipeline Report Executive Summary
3. COVID-19 Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. COVID-19 Clinical Trial Therapeutics
6. COVID-19 Pipeline: Late Stage Products (Pre-registration)
7. COVID-19 Pipeline: Late Stage Products (Phase III)
8. COVID-19 Pipeline: Mid Stage Products (Phase II)
9. COVID-19 Pipeline: Early Stage Products (Phase I)
10. COVID-19 Pipeline Therapeutic Assessment
11. Inactive Products in the COVID-19 Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key COVID-19 Companies
14. Key Products in the COVID-19 Pipeline
15. Unmet Needs
16. COVID-19 Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix

Download Sample PDF Report to know more about @ https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Onycholysis Market: https://www.delveinsight.com/report-store/onycholysis-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Hepatic Encephalopathy Market: https://www.delveinsight.com/report-store/hepatic-encephalopathy-market
• Hyperkalemia Market: https://www.delveinsight.com/report-store/hyperkalemia-treatment-market
• Juvenile Rheumatoid Arthritis Market: https://www.delveinsight.com/report-store/juvenile-rheumatoid-arthritis-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Osteosarcoma Market: https://www.delveinsight.com/infographics/osteosarcoma-market
• Treatment Resistant Depression Market: https://www.delveinsight.com/infographics/treatment-resistant-depression-market
• Triple Negative Breast Cancer Market: https://www.delveinsight.com/report-store/triple-negative-breast-cancer-tnbc-market
• Acute Lung Injury Market: https://www.delveinsight.com/report-store/acute-lung-injury-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Pipline landscape Report 2022 - Clinical Trials, FDA Approvals and Therapies by DelveInsight here

News-ID: 2867752 • Views:

More Releases from DelveInsight Business Research

Herpes Zoster Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight
Herpes Zoster Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Herpes Zoster pipeline constitutes 18+ key companies continuously working towards developing 20+ Herpes Zoster treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Herpes Zoster Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Herpes Zoster Market. The Herpes
Acute Myeloid Leukemia Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight
Acute Myeloid Leukemia Pipeline 2026: Key Companies, MOA, ROA, and Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Myeloid Leukemia pipeline constitutes 100+ key companies continuously working towards developing 110+ Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acute Myeloid Leukemia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
Axillary Hyperhidrosis Market: Accelerating Growth and Pipeline Impact by 2034 - DelveInsight
Axillary Hyperhidrosis Market: Accelerating Growth and Pipeline Impact by 2034 - …
DelveInsight's "Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Axillary Hyperhidrosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axillary Hyperhidrosis Market Forecast https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Chronic Wounds Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight
Chronic Wounds Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emergin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 3+ key companies continuously working towards developing 3+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also

All 5 Releases


More Releases for Market:

Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview: The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
India Payment Services Market, Industry, Market Revenue, Market Sales, Market Sh …
Overview of India Payment Service Market India payment services market, which has traditionally been dominated by cash, witnessed advancement towards digital transactions both in terms of value and volume during the demonetization phase in India. The total market size for the India Payment service market has raised from INR ~ trillion in FY’16 to INR ~ trillion in FY21, during the review period. Regulatory authorities such as the Reserve Bank of
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized